Kozeta Miliku1, Anna Vinkhuyzen2, Laura Me Blanken3, John J McGrath2, Darryl W Eyles2, Thomas H Burne2, Albert Hofman4, Henning Tiemeier5, Eric Ap Steegers6, Romy Gaillard1, Vincent Wv Jaddoe7. 1. Generation R Study Group, Department of Epidemiology, Department of Paediatrics. 2. Queensland Brain Institute, The University of Queensland, Brisbane, Australia; and Queensland Centre for Mental Health Research, Park Centre for Mental Health, Wacol, Australia. 3. Generation R Study Group, Department of Child and Adolescent Psychiatry, and. 4. Department of Epidemiology. 5. Department of Epidemiology, Department of Child and Adolescent Psychiatry, and. 6. Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center, Rotterdam, Netherlands; 7. Generation R Study Group, Department of Epidemiology, Department of Paediatrics, v.jaddoe@erasmusmc.nl.
Abstract
BACKGROUND: Maternal vitamin D deficiency during pregnancy may affect fetal outcomes. OBJECTIVE: The objective of this study was to examine whether maternal 25-hydroxyvitamin D [25(OH)D] concentrations in pregnancy affect fetal growth patterns and birth outcomes. DESIGN: This was a population-based prospective cohort in Rotterdam, Netherlands in 7098 mothers and their offspring. We measured 25(OH)D concentrations at a median gestational age of 20.3 wk (range: 18.5-23.3 wk). Vitamin D concentrations were analyzed continuously and in quartiles. Fetal head circumference and body length and weight were estimated by repeated ultrasounds, and preterm birth (gestational age <37 wk) and small size for gestational age (less than the fifth percentile) were determined. RESULTS: Adjusted multivariate regression analyses showed that, compared with mothers with second-trimester 25(OH)D concentrations in the highest quartile, those with 25(OH)D concentrations in the lower quartiles had offspring with third-trimester fetal growth restriction, leading to a smaller head circumference, shorter body length, and lower body weight at birth (all P < 0.05). Mothers who had 25(OH)D concentrations in the lowest quartile had an increased risk of preterm delivery (OR: 1.72; 95% CI: 1.14, 2.60) and children who were small for gestational age (OR: 2.07; 95% CI: 1.33, 3.22). The estimated population attributable risk of 25(OH)D concentrations <50 nmol/L for preterm birth or small size for gestational age were 17.3% and 22.6%, respectively. The observed associations were not based on extreme 25(OH)D deficiency, but presented within the common ranges. CONCLUSIONS: Low maternal 25(OH)D concentrations are associated with proportional fetal growth restriction and with an increased risk of preterm birth and small size for gestational age at birth. Further studies are needed to investigate the causality of these associations and the potential for public health interventions.
BACKGROUND: Maternal vitamin D deficiency during pregnancy may affect fetal outcomes. OBJECTIVE: The objective of this study was to examine whether maternal 25-hydroxyvitamin D [25(OH)D] concentrations in pregnancy affect fetal growth patterns and birth outcomes. DESIGN: This was a population-based prospective cohort in Rotterdam, Netherlands in 7098 mothers and their offspring. We measured 25(OH)D concentrations at a median gestational age of 20.3 wk (range: 18.5-23.3 wk). Vitamin D concentrations were analyzed continuously and in quartiles. Fetal head circumference and body length and weight were estimated by repeated ultrasounds, and preterm birth (gestational age <37 wk) and small size for gestational age (less than the fifth percentile) were determined. RESULTS: Adjusted multivariate regression analyses showed that, compared with mothers with second-trimester 25(OH)D concentrations in the highest quartile, those with 25(OH)D concentrations in the lower quartiles had offspring with third-trimester fetal growth restriction, leading to a smaller head circumference, shorter body length, and lower body weight at birth (all P < 0.05). Mothers who had 25(OH)D concentrations in the lowest quartile had an increased risk of preterm delivery (OR: 1.72; 95% CI: 1.14, 2.60) and children who were small for gestational age (OR: 2.07; 95% CI: 1.33, 3.22). The estimated population attributable risk of 25(OH)D concentrations <50 nmol/L for preterm birth or small size for gestational age were 17.3% and 22.6%, respectively. The observed associations were not based on extreme 25(OH)D deficiency, but presented within the common ranges. CONCLUSIONS: Low maternal 25(OH)D concentrations are associated with proportional fetal growth restriction and with an increased risk of preterm birth and small size for gestational age at birth. Further studies are needed to investigate the causality of these associations and the potential for public health interventions.
Authors: B O Verburg; E A P Steegers; M De Ridder; R J M Snijders; E Smith; A Hofman; H A Moll; V W V Jaddoe; J C M Witteman Journal: Ultrasound Obstet Gynecol Date: 2008-04 Impact factor: 7.299
Authors: Sarah R Crozier; Nicholas C Harvey; Hazel M Inskip; Keith M Godfrey; Cyrus Cooper; Siân M Robinson Journal: Am J Clin Nutr Date: 2012-05-23 Impact factor: 7.045
Authors: Romy Gaillard; Eric Ap Steegers; Johan C de Jongste; Albert Hofman; Vincent Wv Jaddoe Journal: Int J Epidemiol Date: 2014-03-05 Impact factor: 7.196
Authors: Lisa M Bodnar; Janet M Catov; Joseph M Zmuda; Margaret E Cooper; Meredith S Parrott; James M Roberts; Mary L Marazita; Hyagriv N Simhan Journal: J Nutr Date: 2010-03-03 Impact factor: 4.798
Authors: Nicholas C Harvey; Rebecca J Moon; Avan Aihie Sayer; Georgia Ntani; Justin H Davies; M Kassim Javaid; Sian M Robinson; Keith M Godfrey; Hazel M Inskip; Cyrus Cooper Journal: J Clin Endocrinol Metab Date: 2013-12-20 Impact factor: 5.958
Authors: Kozeta Miliku; Janine F Felix; Trudy Voortman; Henning Tiemeier; Darryl W Eyles; Thomas H Burne; John J McGrath; Vincent W V Jaddoe Journal: Matern Child Nutr Date: 2018-09-21 Impact factor: 3.092
Authors: Folami Y Ideraabdullah; Anthony M Belenchia; Cheryl Susan Rosenfeld; Seth W Kullman; Megan Knuth; Debrata Mahapatra; Michael Bereman; Edward D Levin; Catherine Ann Peterson Journal: J Endocrinol Date: 2019-03-01 Impact factor: 4.286
Authors: Andrea L Darling; Margaret P Rayman; Colin D Steer; Jean Golding; Susan A Lanham-New; Sarah C Bath Journal: Br J Nutr Date: 2017-07-12 Impact factor: 3.718
Authors: Andre Sourander; Subina Upadhyaya; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; Sanju Silwal; Minna Sucksdorff; Ian W McKeague; Alan S Brown Journal: Biol Psychiatry Date: 2021-07-21 Impact factor: 13.382
Authors: Minna Sucksdorff; Alan S Brown; Roshan Chudal; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; David Gyllenberg; Andre Sourander Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-12-19 Impact factor: 8.829